Study 111-903 will generate baseline growth data in children with ISS by collecting growth measurements and other variables of interest.
Age: 2 - 16 years
Gender: All
We've found 2 total result s for "Dwarfism".
This will be an open-label, randomized, multicenter, efficacy and safety study of weekly MOD-4023 compared to daily Genotropin therapy in pre-pubertal children with growth hormone deficiency.
Age: 3 - 11 years
Gender: All